Gavin T. Jones Purchases 50,000 Shares of EKF Diagnostics Holdings plc (LON:EKF) Stock

EKF Diagnostics Holdings plc (LON:EKF) insider Gavin T. Jones acquired 50,000 shares of EKF Diagnostics stock in a transaction dated Tuesday, March 25th. The shares were acquired at an average price of GBX 22 ($0.28) per share, with a total value of £11,000 ($14,241.33).

EKF Diagnostics Trading Down 4.9 %

EKF Diagnostics stock opened at GBX 22.11 ($0.29) on Wednesday. EKF Diagnostics Holdings plc has a 1 year low of GBX 18.40 ($0.24) and a 1 year high of GBX 33.80 ($0.44). The firm’s 50 day moving average price is GBX 23.30 and its two-hundred day moving average price is GBX 25.88. The firm has a market cap of £98.28 million, a price-to-earnings ratio of 20.58 and a beta of 0.57. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.77 and a current ratio of 4.60.

EKF Diagnostics (LON:EKF) last issued its quarterly earnings results on Tuesday, March 25th. The company reported GBX 1.38 ($0.02) earnings per share for the quarter. EKF Diagnostics had a return on equity of 7.03% and a net margin of 9.37%. On average, research analysts predict that EKF Diagnostics Holdings plc will post 2.2987842 EPS for the current fiscal year.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.